| Status | Study |
| Recruiting |
Study Name: Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma Condition: Glioma Anaplastic Astrocytoma Date: 2017-02-20 Interventions: Biological: Neural stem cells loaded with an oncolytic adenovirus The primary objectives are to evaluate |
| Not yet recruiting |
Study Name: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children Condition: Malignant Glioma Anaplastic Astrocytoma Date: 2017-02-02 Interventions: Biological: Polio/Rhinovirus Recombinant (PVSRIPO) PVSRIPO will be delivered intratumorally by CED using |
| Not yet recruiting |
Study Name: Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma Condition: Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System Glioblastoma Date: 2017-01-13 Interventions: Procedure: Laser Interstitial Thermal Therapy |
| Recruiting |
Study Name: TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma Condition: Brain Tumor Astrocytoma Astroglioma Date: 2016-10-21 Interventions: Drug: TG02 Phase I: Two treatm |
| Recruiting |
Study Name: Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children Condition: Glioblastoma Multiforme Anaplastic Astrocytoma Date: 2016-08-24 Interventions: Drug: Cabozantinib Subjects will receive Cabozantinib |
| Recruiting |
Study Name: Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Condition: Anaplastic Astrocytoma Recurrent Anaplast Date: 2016-06-03 Interventions: Drug: Eflornithine Eflornithin |
| Recruiting |
Study Name: Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Condition: Glioblastoma Anaplastic Astrocytoma Date: 2016-05-27 Interventions: Drug: Intra-arterial Cetuximab Drug: Intra |
| No longer available |
Study Name: Expanded Access to ANG1005 for Individual Patients Condition: Anaplastic Astrocytoma Anaplastic Oligodendroglioma Date: 2016-04-27 Interventions: Drug: ANG1005 |
| Not yet recruiting |
Study Name: Phase II Pediatric Study With Dabrafenib in HGG Patients Condition: Anaplastic Astrocytoma Glioblastoma Date: 2016-02-04 Interventions: Drug: dabrafenib dabrafenib oral, twice daily. Patient dose based on weight and age. Patients will recei |
| Recruiting |
Study Name: Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors Condition: Medulloblastoma Astrocytoma, Grade III Glioblastoma Date: 2015-12-27 Interventions: Drug: Mebendazole chewable mebendazole tablets that can also be crushed and mixed with food or drink to |